dbACP: A Comprehensive Database of Anti-Cancer Peptides

dbacp06198

General Description

Peptide name : Tat (47-57)

Source/Organism : Synthetic construct

Linear/Cyclic : Linear

Chirality : L

Sequence Information

Sequence : YGRKKRRQRRR

Peptide length: 11

C-terminal modification: Linear

N-terminal modification : Free

Non-natural peptide information: None

Activity Information

Assay type : MTT/MTS assay

Assay time : 6h

Activity : At 100 µM 60% viablity

Cell line : HeLa

Cancer type : Cervical cancer

Other activity : Anti-microbial activity

Physicochemical Properties

Amino acid composition bar chart :

Molecular mass : 1559.8278 Dalton

Aliphatic index : 0

Instability index : 204.736

Hydrophobicity (GRAVY) : -3.636

Isoelectric point : 12

Charge (pH 7) : 7.757

Aromaticity : 0.090

Molar extinction coefficient (cysteine, cystine): (1490, 1490)

Hydrophobic/hydrophilic ratio : 0.1

hydrophobic moment : 0.3096

Missing amino acid : C,W,H,T,P,M,I,E,F,S,D,L,N,A,V

Most occurring amino acid : R

Most occurring amino acid frequency : 6

Least occurring amino acid : Y

Least occurring amino acid frequency : 1

Structural Information

3D structure :

Secondary structure fraction (Helix, Turn, Sheet): (0.1, 0.0, 0.0)

SMILES Notation: N=C(N)NCCC[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CCCNC(=N)N)NC(=O)CNC(=O)[C@@H](N)Cc1ccc(O)cc1)C(=O)O

Secondary Structure :

Method Prediction
GOR HHHHHHHHHHT
Chou-Fasman (CF) CHHHHHHHCCC
Neural Network (NN) CCCCCCCCCCH
Joint/Consensus CHHHHHHHCCC

Molecular Descriptors and ADMET Properties

Molecular Descriptors: Click here to download

ADMET Properties: Click here to download

Cross Referencing databases

Pubmed Id : 12417587

Uniprot : Not available

PDB : Not available

CancerPPD : Not available

ApIAPDB : Not available

CancerPPD2 ID : Not available

Reference

1 : Takeshima K, et al. Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes. J Biol Chem. 2003; 278:1310-5. doi: 10.1074/jbc.M208762200

Literature

Paper title : Translocation of analogues of the antimicrobial peptides magainin and buforin across human cell membranes.

Doi : https://doi.org/10.1074/jbc.M208762200

Abstract : Cationic antimicrobial peptides play important roles in innate immunity. Compared with extensive studies on peptide-bacteria interactions, little is known about peptide-human cell interactions. Using human cervical carcinoma HeLa and fibroblastic TM12 cells, we investigated the cellular uptake of fluorescent analogues of the two representative antimicrobial peptides magainin 2 and buforin 2 in comparison with the representative Arg-rich cell-penetrating Tat-(47-57) peptide (YGRKKRRQRRR). The dose, time, temperature, and energy dependence of translocation suggested that the three peptides cross cell membranes through different mechanisms. The magainin peptide was internalized within a time scale of tens of minutes. The cooperative concentration dependence of uptake suggested that the peptide forms a pore as an intermediate similar to the observations in model membranes. Furthermore, the translocation was coupled with cytotoxicity, which was larger for tumor HeLa cells. In contrast, the buforin peptide translocated within 10 min by a temperature-independent, less concentration-dependent passive mechanism without showing any significant cytotoxicity at the highest concentration investigated (100 microm). The uptake of the Tat peptide was proportional to the peptide concentration, and the concentration dependence was lost upon ATP depletion. The peptide exhibited a moderate cytotoxicity at higher concentrations. The time course did not show saturation even after 120 min. The buforin peptide, covalently attached to the 28-kDa green fluorescent protein, also entered cells, suggesting a potency of the peptide as a vector for macromolecular delivery into cells. However, the mechanism appeared to be different from that of the parent peptide.